Correlation Between Cann American and Mydecine Innovations

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cann American and Mydecine Innovations at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cann American and Mydecine Innovations into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cann American Corp and Mydecine Innovations Group, you can compare the effects of market volatilities on Cann American and Mydecine Innovations and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cann American with a short position of Mydecine Innovations. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cann American and Mydecine Innovations.

Diversification Opportunities for Cann American and Mydecine Innovations

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Cann and Mydecine is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Cann American Corp and Mydecine Innovations Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mydecine Innovations and Cann American is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cann American Corp are associated (or correlated) with Mydecine Innovations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mydecine Innovations has no effect on the direction of Cann American i.e., Cann American and Mydecine Innovations go up and down completely randomly.

Pair Corralation between Cann American and Mydecine Innovations

Given the investment horizon of 90 days Cann American is expected to generate 3.59 times less return on investment than Mydecine Innovations. But when comparing it to its historical volatility, Cann American Corp is 2.88 times less risky than Mydecine Innovations. It trades about 0.07 of its potential returns per unit of risk. Mydecine Innovations Group is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  44.00  in Mydecine Innovations Group on August 29, 2024 and sell it today you would lose (43.64) from holding Mydecine Innovations Group or give up 99.18% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cann American Corp  vs.  Mydecine Innovations Group

 Performance 
       Timeline  
Cann American Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cann American Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Cann American sustained solid returns over the last few months and may actually be approaching a breakup point.
Mydecine Innovations 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

Cann American and Mydecine Innovations Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cann American and Mydecine Innovations

The main advantage of trading using opposite Cann American and Mydecine Innovations positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cann American position performs unexpectedly, Mydecine Innovations can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mydecine Innovations will offset losses from the drop in Mydecine Innovations' long position.
The idea behind Cann American Corp and Mydecine Innovations Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk